Stockscreener 앱 받기
0.00
100.00%
-0.365
시간 외 거래:
.38
0.38
+
전일 마감가:
$0.365
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$21.63M
수익:
-
순이익/손실:
$-41.95M
주가수익비율:
0.00
EPS:
-0.83
순현금흐름:
$-38.34M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$0.98
Elevation Oncology Inc Stock (ELEV) Company Profile
명칭
Elevation Oncology Inc
전화
(716) 371-1125
주소
101 FEDERAL STREET, BOSTON
ELEV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELEV
Elevation Oncology Inc
|
0.00 | 21.63M | 0 | -41.95M | -38.34M | -0.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Elevation Oncology Inc Stock (ELEV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-24 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2025-03-21 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-21 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-01-03 | 개시 | William Blair | Outperform |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2024-03-01 | 개시 | JMP Securities | Mkt Outperform |
| 2023-05-30 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2021-12-23 | 개시 | H.C. Wainwright | Buy |
모두보기
Elevation Oncology Inc 주식(ELEV)의 최신 뉴스
Breakout Zone: How institutional buying supports Elevation Oncology Inc stock2025 Market Overview & Short-Term Trading Alerts - BỘ NỘI VỤ
What insider trading reveals about Elevation Oncology Inc. stockJuly 2025 Recap & High Accuracy Buy Signal Tips - Newser
Is Elevation Oncology Inc. stock ready for breakoutWeekly Trade Recap & Consistent Income Trade Recommendations - Newser
Elevation Oncology announces CSO departure - MSN
Rare NRG1 Fusion Market Research Report 2025-2035 Featuring Merus, Hummingbird Bioscience, Elevation Oncology (Concentra Biosciences), and Shenzhen Salubris PharmaceuticalsResearchAndMarkets.com - Business Wire
Can Elevation Oncology Inc. stock hit analyst price targetsJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
What margin trends mean for Elevation Oncology Inc. stockTake Profit & Real-Time Chart Breakout Alerts - newser.com
Using data models to predict Elevation Oncology Inc. stock movementJuly 2025 Recap & AI Powered Market Trend Analysis - newser.com
Visualizing Elevation Oncology Inc. stock with heatmapsAnalyst Downgrade & Fast Entry High Yield Stock Tips - newser.com
Predicting Elevation Oncology Inc. trend using moving averagesJuly 2025 Movers & Verified Chart Pattern Trade Signals - newser.com
Is Elevation Oncology Inc. showing signs of accumulationJuly 2025 EndofMonth & Reliable Price Action Trade Plans - newser.com
What’s next for Elevation Oncology Inc. stock priceEntry Point & Safe Capital Growth Trade Ideas - newser.com
Measuring Elevation Oncology Inc.’s beta against major indicesPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
What Fibonacci levels say about Elevation Oncology Inc. reboundMarket Activity Summary & Technical Pattern Based Buy Signals - newser.com
Can Elevation Oncology Inc. stock sustain market leadershipWeekly Loss Report & Weekly Sector Rotation Insights - newser.com
Will Elevation Oncology Inc. stock split again soonJuly 2025 Levels & Safe Capital Investment Plans - newser.com
Can Elevation Oncology Inc. stock beat analyst upgradesAnalyst Downgrade & Low Drawdown Momentum Ideas - newser.com
What to do if you’re stuck in Elevation Oncology Inc.Market Trend Review & Free Reliable Trade Execution Plans - newser.com
Will Elevation Oncology Inc. stock deliver consistent dividends2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Is Elevation Oncology Inc. stock a contrarian buyJuly 2025 PreEarnings & AI Enhanced Trading Alerts - newser.com
Can Elevation Oncology Inc. stock sustain free cash flow growthJuly 2025 Institutional & Verified Short-Term Plans - newser.com
Why Elevation Oncology Inc. is moving todayJuly 2025 Market Mood & Pattern Based Trade Signal System - newser.com
Why Elevation Oncology Inc. stock is favored by top institutionsVolume Spike & Consistent Return Strategy Ideas - Fundação Cultural do Pará
Elevation Oncology Inc (ELEV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.44%
0.91%
자본화:
|
볼륨(24시간):